| Literature DB >> 28487731 |
Murdani Abdullah1, Ari Fahrial Syam1, Sofy Meilany2, Bayu Laksono1, Oryza Gryagus Prabu1, Heri Setiyo Bekti2, Lili Indrawati3, Dadang Makmun1.
Abstract
Annona muricata, commonly known as soursop, contains annonacin, acetogenin, and polyphenol which are known to have chemopreventive effects on cancer. In this study, we tend to evaluate the apoptosis-inducing effect of soursop (Annona muricata) leaf extract on the colorectal cancer cell line COLO-205 through the activities of caspase-3 which is a marker of cell apoptosis. Cell cultures were incubated with soursop leaf with a concentration of 10 μg/ml and then compared with those of the incubated positive control leucovorin 10 μg/ml and placebo as a negative control. The apoptotic activity of caspase-3 was measured with ELISA. After the administration of each treatment in the colorectal cancer cell line COLO-205, the expression of caspase-3 activity was 1422 ng/ml after incubation with the extract of Annona muricata leaves, 1373 ng/ml after the administration of leucovorin, and 1297 ng/ml in the one with placebo. Annona muricata leaf extract elevated caspase-3 by 1.09 times compared to that of the pure cell line. Annona muricata leaf extract had a higher value of caspase-3 activity than leucovorin and placebo in the COLO-205 colorectal cancer cell line. These results may suggest that Annona muricata leaf extract had anticancer properties by enhancing caspase-3 activity which is a proapoptotic marker.Entities:
Year: 2017 PMID: 28487731 PMCID: PMC5401745 DOI: 10.1155/2017/4357165
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
Figure 1COLO-205 cell lines were treated with ESFAM, EIFAM, leucovorin, and 5FU for 48 h. Cell viability was determined using MTT assay. The results represent the mean ± SD of three independent experiments.
Result of cell viability assay using MTT assay in percentage. This showed that ESFAM extract has the best result compared to others.
| Cell viability (%) | |
|---|---|
| ESFAM |
|
| EIFAM | 114.21 |
| FU | 83.15 |
| Leucovorin | 100.71 |
Figure 2Caspase-3 activity of ESFAM, leucovorin, and placebo with 10 ppm and 8 ppm dosages. ESFAM extract gives a higher result at 10 ppm dosage compared to that at 8 ppm dosage.